Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Robert Griffin to Humans

This is a "connection" page, showing publications Robert Griffin has written about Humans.

 
Connection Strength
  
 
 
1.082
  
  1. Griffin RJ, Guha C. Innovations in Physics, Biology and Clinical Translation of Spatially Fractionated and FLASH Radiotherapy. Semin Radiat Oncol. 2024 Jul; 34(3):259-261.
    View in: PubMed
    Score: 0.039
  2. Jenkins SV, Johnsrud AJ, Dings RPM, Griffin RJ. Bystander Effects in Spatially Fractionated Radiation Therapy: From Molecule To Organism To Clinical Implications. Semin Radiat Oncol. 2024 Jul; 34(3):284-291.
    View in: PubMed
    Score: 0.039
  3. Song CW, Terezakis S, Park WY, Paek SH, Kim MS, Cho LC, Griffin RJ. Preferential Tumor Vascular Damage Is the Common Antitumor Mechanism of High-Dose Hypofractionated Radiation Therapy: SABR, Spatially Fractionated Radiation Therapy, and FLASH Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 11 01; 117(3):701-704.
    View in: PubMed
    Score: 0.036
  4. Stolarz AJ, Chhetri BP, Borrelli MJ, Jenkins SV, Jamshidi-Parsian A, Phillips JH, Fologea D, Gandy J, Griffin RJ. Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy. Int J Mol Sci. 2022 Oct 02; 23(19).
    View in: PubMed
    Score: 0.034
  5. Hamzah RN, Alghazali KM, Biris AS, Griffin RJ. Exosome Traceability and Cell Source Dependence on Composition and Cell-Cell Cross Talk. Int J Mol Sci. 2021 May 19; 22(10).
    View in: PubMed
    Score: 0.031
  6. Griffin RJ, Limoli CL, Simone CB. Radiation Research Special Issue: New Beam Delivery Modalities are Shaping the Future of Radiotherapy. Radiat Res. 2020 12 01; 194(6):567-570.
    View in: PubMed
    Score: 0.030
  7. Griffin RJ, Prise KM, McMahon SJ, Zhang X, Penagaricano J, Butterworth KT. History and current perspectives on the biological effects of high-dose spatial fractionation and high dose-rate approaches: GRID, Microbeam & FLASH radiotherapy. Br J Radiol. 2020 Sep 01; 93(1113):20200217.
    View in: PubMed
    Score: 0.029
  8. Corry PM, Griffin RJ. A Radiation Mitigator as a Potential Treatment for COVID-19. Radiat Res. 2020 06 01; 193(6):505.
    View in: PubMed
    Score: 0.029
  9. Griffin RJ, Ahmed MM, Amendola B, Belyakov O, Bentzen SM, Butterworth KT, Chang S, Coleman CN, Djonov V, Formenti SC, Glatstein E, Guha C, Kalnicki S, Le QT, Loo BW, Mahadevan A, Massaccesi M, Maxim PG, Mohiuddin M, Mohiuddin M, Mayr NA, Obcemea C, Petersson K, Regine W, Roach M, Romanelli P, Simone CB, Snider JW, Spitz DR, Vikram B, Vozenin MC, Abdel-Wahab M, Welsh J, Wu X, Limoli CL. Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2020 07 15; 107(4):766-778.
    View in: PubMed
    Score: 0.029
  10. Koturbash I, Griffin RJ. Harnessing epigenetics and metabolism to modulate tissue response to radiotherapy. Int J Radiat Biol. 2019 04; 95(4):379-381.
    View in: PubMed
    Score: 0.027
  11. Boysen G, Jamshidi-Parsian A, Davis MA, Siegel ER, Simecka CM, Kore RA, Dings RPM, Griffin RJ. Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice. Int J Radiat Biol. 2019 04; 95(4):436-442.
    View in: PubMed
    Score: 0.027
  12. Griffin RJ, Dings RPM, Makhoul I. Further rationale for optimal combined modality treatments. Oncotarget. 2017 04 18; 8(16):25831-25832.
    View in: PubMed
    Score: 0.023
  13. Griffin RJ. Scientific uncertainty in media content: Some reflections on this special issue. Public Underst Sci. 2016 11; 25(8):1009-1013.
    View in: PubMed
    Score: 0.023
  14. Przybyla BD, Shafirstein G, Vishal SJ, Dennis RA, Griffin RJ. Molecular changes in bone marrow, tumor and serum after conductive ablation of murine 4T1 breast carcinoma. Int J Oncol. 2014 Feb; 44(2):600-8.
    View in: PubMed
    Score: 0.019
  15. Asur R, Butterworth KT, Penagaricano JA, Prise KM, Griffin RJ. High dose bystander effects in spatially fractionated radiation therapy. Cancer Lett. 2015 Jan 01; 356(1):52-7.
    View in: PubMed
    Score: 0.019
  16. Barnes KD, Shafirstein G, Webber JS, Koonce NA, Harris Z, Griffin RJ. Hyperthermia-enhanced indocyanine green delivery for laser-induced thermal ablation of carcinomas. Int J Hyperthermia. 2013 Aug; 29(5):474-9.
    View in: PubMed
    Score: 0.018
  17. Upreti M, Jamshidi-Parsian A, Apana S, Berridge M, Fologea DA, Koonce NA, Henry RL, Griffin RJ. Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature. J Mol Med (Berl). 2013 Apr; 91(4):497-506.
    View in: PubMed
    Score: 0.017
  18. Suva LJ, Washam C, Nicholas RW, Griffin RJ. Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol. 2011 Apr; 7(4):208-18.
    View in: PubMed
    Score: 0.015
  19. Jia D, Koonce NA, Halakatti R, Li X, Yaccoby S, Swain FL, Suva LJ, Hennings L, Berridge MS, Apana SM, Mayo K, Corry PM, Griffin RJ. Repression of multiple myeloma growth and preservation of bone with combined radiotherapy and anti-angiogenic agent. Radiat Res. 2010 Jun; 173(6):809-17.
    View in: PubMed
    Score: 0.015
  20. Griffin RJ, Dings RP, Jamshidi-Parsian A, Song CW. Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors. Int J Hyperthermia. 2010; 26(3):256-63.
    View in: PubMed
    Score: 0.014
  21. Griffin RJ, Corry PM. Commentary on classic paper in hyperthermic oncology 'Tumour oxygenation is increased by hyperthermia at mild temperatures' by CW Song et al., 1996. Int J Hyperthermia. 2009 Mar; 25(2):96-8.
    View in: PubMed
    Score: 0.013
  22. Lee BW, Olin MR, Johnson GL, Griffin RJ. In vitro and in vivo apoptosis detection using membrane permeant fluorescent-labeled inhibitors of caspases. Methods Mol Biol. 2008; 414:109-35.
    View in: PubMed
    Score: 0.012
  23. Visaria R, Bischof JC, Loren M, Williams B, Ebbini E, Paciotti G, Griffin R. Nanotherapeutics for enhancing thermal therapy of cancer. Int J Hyperthermia. 2007 Sep; 23(6):501-11.
    View in: PubMed
    Score: 0.012
  24. Dings RP, Loren M, Heun H, McNiel E, Griffioen AW, Mayo KH, Griffin RJ. Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization. Clin Cancer Res. 2007 Jun 01; 13(11):3395-402.
    View in: PubMed
    Score: 0.012
  25. Griffin RJ, Molema G, Dings RP. Angiogenesis treatment, new concepts on the horizon. Angiogenesis. 2006; 9(2):67-72.
    View in: PubMed
    Score: 0.011
  26. Dings RP, Williams BW, Song CW, Griffioen AW, Mayo KH, Griffin RJ. Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells. Int J Cancer. 2005 Jun 10; 115(2):312-9.
    View in: PubMed
    Score: 0.010
  27. Xie SC, Tai CW, Morton CJ, Ma L, Huang SC, Wittlin S, Du Y, Hu Y, Dogovski C, Salimimarand M, Griffin R, England D, de la Cruz E, Deni I, Yeo T, Burkhard AY, Striepen J, Schindler KA, Crespo B, Gamo FJ, Khandokar Y, Hutton CA, Rabie T, Birkholtz LM, Famodimu MT, Delves MJ, Bolsher J, Koolen KMJ, van der Laak R, Aguiar ACC, Pereira DB, Guido RVC, Creek DJ, Fidock DA, Dick LR, Brand SL, Gould AE, Langston S, Griffin MDW, Tilley L. A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo. PLoS Pathog. 2024 Dec; 20(12):e1012429.
    View in: PubMed
    Score: 0.010
  28. Snider JW, Mayr NA, Molitoris J, Chhabra AM, Mossahebi S, Griffin R, Mohiuddin M, Zhang H, Amendola B, Tubin S, Kang M, Limoli C, Marter K, Perez N, Rustin GO, Mahadevan A, Coleman CN, Ahmed M, Simone CB. The Radiosurgery Society Working Groups on GRID, LATTICE, Microbeam, and FLASH Radiotherapies: Advancements Symposium and Subsequent Progress Made. Pract Radiat Oncol. 2025 May-Jun; 15(3):300-307.
    View in: PubMed
    Score: 0.010
  29. Chen H, Shah A, Kato S, Griffin R, Zhang S, Pusalkar S, Cohen L, Li Y, Chowdhury SK, Zhu SX. Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects. Drug Metab Dispos. 2024 Sep 16; 52(10):1115-1123.
    View in: PubMed
    Score: 0.010
  30. Jamshidi-Parsian A, Jenkins SV, Tran A, Bragg A, Davis R, Griffin C, Siegel E, Dings RPM, Griffin RJ, Boysen G. CB-839 induces reversible dormancy in lung tumor-cells. Eur J Pharmacol. 2024 Nov 05; 982:176912.
    View in: PubMed
    Score: 0.010
  31. Bashiru M, Rayaan M, Ali N, Jenkins SV, Oyebade A, Rahman MS, Griffin RJ, Oyelere AK, Siraj N. Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines. ACS Appl Bio Mater. 2024 08 19; 7(8):5359-5368.
    View in: PubMed
    Score: 0.010
  32. Hanley MJ, Zhang S, Griffin R, Zhu SX, Fram RJ, Lin J, Venkatakrishnan K, Gupta N. A phase 1 study to assess the absolute bioavailability, mass balance, pharmacokinetics, metabolism, and excretion of [14C]-mobocertinib, an oral inhibitor of EGFR exon 20 insertion mutations, in healthy participants. Invest New Drugs. 2024 Aug; 42(4):343-352.
    View in: PubMed
    Score: 0.010
  33. Cheng B, Rhodus NL, Williams B, Griffin RJ. Detection of apoptotic cells in whole saliva of patients with oral premalignant and malignant lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Apr; 97(4):465-70.
    View in: PubMed
    Score: 0.010
  34. Jenkins SV, Shah S, Jamshidi-Parsian A, Mortazavi A, Kristian H, Boysen G, Vang KB, Griffin RJ, Rajaram N, Dings RPM. Acquired Radiation Resistance Induces Thiol-dependent Cisplatin Cross-resistance. Radiat Res. 2024 02 01; 201(2):174-187.
    View in: PubMed
    Score: 0.009
  35. Li H, Mayr NA, Griffin RJ, Zhang H, Pokhrel D, Grams M, Penagaricano J, Chang S, Spraker MB, Kavanaugh J, Lin L, Sheikh K, Mossahebi S, Simone CB, Roberge D, Snider JW, Sabouri P, Molineu A, Xiao Y, Benedict SH. Overview and Recommendations for Prospective Multi-institutional Spatially Fractionated Radiation Therapy Clinical Trials. Int J Radiat Oncol Biol Phys. 2024 Jul 01; 119(3):737-749.
    View in: PubMed
    Score: 0.009
  36. Forson M, Bashiru M, Macchi S, Singh S, Anderson AD, Sayyed S, Ishtiaq A, Griffin R, Ali N, Oyelere AK, Berry B, Siraj N. Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy. ACS Appl Bio Mater. 2023 12 18; 6(12):5662-5675.
    View in: PubMed
    Score: 0.009
  37. Todorova VK, Byrum SD, Mackintosh SG, Jamshidi-Parsian A, Gies AJ, Washam CL, Jenkins SV, Spiva T, Bowman E, Reyna NS, Griffin RJ, Makhoul I. Exosomal MicroRNA and Protein Profiles of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells. Int J Mol Sci. 2023 Aug 23; 24(17).
    View in: PubMed
    Score: 0.009
  38. Gupta N, Hanley MJ, Griffin RJ, Zhang P, Venkatakrishnan K, Sinha V. Clinical Pharmacology of Brigatinib: A Next-Generation Anaplastic Lymphoma Kinase Inhibitor. Clin Pharmacokinet. 2023 08; 62(8):1063-1079.
    View in: PubMed
    Score: 0.009
  39. Langford DJ, Baron R, Edwards RR, Gewandter JS, Gilron I, Griffin R, Kamerman PR, Katz NP, McDermott MP, Rice ASC, Turk DC, Vollert J, Dworkin RH. What should be the entry pain intensity criteria for chronic pain clinical trials? An IMMPACT update. Pain. 2023 09 01; 164(9):1927-1930.
    View in: PubMed
    Score: 0.009
  40. Sandoval P, Chuang BC, Fallon JK, Smith PC, Chowdhury SK, Griffin RJ, Xia CQ, Iwasaki S, Chothe PP. Sinusoidal Organic Anion-Transporting Polypeptide 1B1/1B3 and Bile Canalicular Multidrug Resistance-Associated Protein 2 Play an Essential Role in the Hepatobiliary Disposition of a Synthetic Cyclic Dinucleotide (STING Agonist). AAPS J. 2022 09 19; 24(6):99.
    View in: PubMed
    Score: 0.009
  41. Griffin RJ, Williams BW, Wild R, Cherrington JM, Park H, Song CW. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response. Cancer Res. 2002 Mar 15; 62(6):1702-6.
    View in: PubMed
    Score: 0.008
  42. Zhang X, Griffin RJ, Galhardo EP, Penagaricano J. Feasibility Study of 3D-VMAT-Based GRID Therapy. Technol Cancer Res Treat. 2022 Jan-Dec; 21:15330338221086420.
    View in: PubMed
    Score: 0.008
  43. McDonald JT, Enguita FJ, Taylor D, Griffin RJ, Priebe W, Emmett MR, Sajadi MM, Harris AD, Clement J, Dybas JM, Aykin-Burns N, Guarnieri JW, Singh LN, Grabham P, Baylin SB, Yousey A, Pearson AN, Corry PM, Saravia-Butler A, Aunins TR, Sharma S, Nagpal P, Meydan C, Foox J, Mozsary C, Cerqueira B, Zaksas V, Singh U, Wurtele ES, Costes SV, Davanzo GG, Galeano D, Paccanaro A, Meinig SL, Hagan RS, Bowman NM, Wolfgang MC, Altinok S, Sapoval N, Treangen TJ, Moraes-Vieira PM, Vanderburg C, Wallace DC, Schisler JC, Mason CE, Chatterjee A, Meller R, Beheshti A. Role of miR-2392 in driving SARS-CoV-2 infection. Cell Rep. 2021 10 19; 37(3):109839.
    View in: PubMed
    Score: 0.008
  44. Xie SC, Metcalfe RD, Mizutani H, Puhalovich T, Hanssen E, Morton CJ, Du Y, Dogovski C, Huang SC, Ciavarri J, Hales P, Griffin RJ, Cohen LH, Chuang BC, Wittlin S, Deni I, Yeo T, Ward KE, Barry DC, Liu B, Gillett DL, Crespo-Fernandez BF, Ottilie S, Mittal N, Churchyard A, Ferguson D, Aguiar ACC, Guido RVC, Baum J, Hanson KK, Winzeler EA, Gamo FJ, Fidock DA, Baud D, Parker MW, Brand S, Dick LR, Griffin MDW, Gould AE, Tilley L. Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome. Proc Natl Acad Sci U S A. 2021 09 28; 118(39).
    View in: PubMed
    Score: 0.008
  45. Kowal DR, Bravo M, Leong H, Bui A, Griffin RJ, Ensor KB, Miranda ML. Bayesian variable selection for understanding mixtures in environmental exposures. Stat Med. 2021 09 30; 40(22):4850-4871.
    View in: PubMed
    Score: 0.008
  46. Vyskocil S, Cardin D, Ciavarri J, Conlon J, Cullis C, England D, Gershman R, Gigstad K, Gipson K, Gould A, Greenspan P, Griffin R, Gulavita N, Harrison S, Hu Z, Hu Y, Hata A, Huang J, Huang SC, Janowick D, Jones M, Kolev V, Langston SP, Lee HM, Li G, Lok D, Ma L, Mai D, Malley J, Matsuda A, Mizutani H, Mizutani M, Molchanova N, Nunes E, Pusalkar S, Renou C, Rowland S, Sato Y, Shaw M, Shen L, Shi Z, Skene R, Soucy F, Stroud S, Xu H, Xu T, Abu-Yousif AO, Zhang J. Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route. J Med Chem. 2021 05 27; 64(10):6902-6923.
    View in: PubMed
    Score: 0.008
  47. Abraham EH, Guidotti G, Rapaport E, Bower D, Brown J, Griffin RJ, Donnelly A, Waitzkin ED, Qamar K, Thompson MA, Ethirajan S, Robinson K. Cystic fibrosis improves COVID-19 survival and provides clues for treatment of SARS-CoV-2. Purinergic Signal. 2021 09; 17(3):399-410.
    View in: PubMed
    Score: 0.008
  48. Gonzalvez F, Vincent S, Baker TE, Gould AE, Li S, Wardwell SD, Nadworny S, Ning Y, Zhang S, Huang WS, Hu Y, Li F, Greenfield MT, Zech SG, Das B, Narasimhan NI, Clackson T, Dalgarno D, Shakespeare WC, Fitzgerald M, Chouitar J, Griffin RJ, Liu S, Wong KK, Zhu X, Rivera VM. Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non-Small Cell Lung Cancer. Cancer Discov. 2021 07; 11(7):1672-1687.
    View in: PubMed
    Score: 0.008
  49. Kore RA, Wang X, Ding Z, Griffin RJ, Tackett AJ, Mehta JL. MSC exosome-mediated cardioprotection in ischemic mouse heart comparative proteomics of infarct and peri-infarct areas. Mol Cell Biochem. 2021 Apr; 476(4):1691-1704.
    View in: PubMed
    Score: 0.008
  50. Wu X, Perez NC, Zheng Y, Li X, Jiang L, Amendola BE, Xu B, Mayr NA, Lu JJ, Hatoum GF, Zhang H, Chang SX, Griffin RJ, Guha C. The Technical and Clinical Implementation of LATTICE Radiation Therapy (LRT). Radiat Res. 2020 Dec 01; 194(6):737-746.
    View in: PubMed
    Score: 0.008
  51. Zhang H, Wu X, Zhang X, Chang SX, Megooni A, Donnelly ED, Ahmed MM, Griffin RJ, Welsh JS, Simone CB, Mayr NA. Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group. Radiat Res. 2020 12 01; 194(6):665-677.
    View in: PubMed
    Score: 0.008
  52. Dadgar S, Troncoso JR, Siegel ER, Curry NM, Griffin RJ, Dings RPM, Rajaram N. Spectroscopic investigation of radiation-induced reoxygenation in radiation-resistant tumors. Neoplasia. 2021 01; 23(1):49-57.
    View in: PubMed
    Score: 0.008
  53. Pakniyat F, Nedaie HA, Mozdarani H, Mahmoudzadeh A, Salimi M, Griffin RJ, Gholami S. Enhanced response of radioresistant carcinoma cell line to heterogeneous dose distribution of grid; the role of high-dose bystander effect. Int J Radiat Biol. 2020 12; 96(12):1585-1596.
    View in: PubMed
    Score: 0.008
  54. Sharma KD, Schaal D, Kore RA, Hamzah RN, Pandanaboina SC, Hayar A, Griffin RJ, Srivatsan M, Reyna NS, Xie JY. Glioma-derived exosomes drive the differentiation of neural stem cells to astrocytes. PLoS One. 2020; 15(7):e0234614.
    View in: PubMed
    Score: 0.007
  55. Ramberger M, Berretta A, Tan JMM, Sun B, Michael S, Yeo T, Theorell J, Bashford-Rogers R, Paneva S, O'Dowd V, Dedi N, Topia S, Griffin R, Ramirez-Franco J, El Far O, Baulac S, Leite MI, Sen A, Jeans A, McMillan D, Marshall D, Anthony D, Lightwood D, Waters P, Irani SR. Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms. Brain. 2020 06 01; 143(6):1731-1745.
    View in: PubMed
    Score: 0.007
  56. Miousse IR, Tobacyk J, Quick CM, Jamshidi-Parsian A, Skinner CM, Kore R, Melnyk SB, Kutanzi KR, Xia F, Griffin RJ, Koturbash I. Reply to Flugge: the anti-metastatic potential of methionine restriction in melanoma. Carcinogenesis. 2020 05 14; 41(3):390-391.
    View in: PubMed
    Score: 0.007
  57. Darrigues E, Nima ZA, Griffin RJ, Anderson JM, Biris AS, Rodriguez A. 3D cultures for modeling nanomaterial-based photothermal therapy. Nanoscale Horiz. 2020 03 01; 5(3):400-430.
    View in: PubMed
    Score: 0.007
  58. Blakely EA, Faddegon B, Tinkle C, Bloch C, Dominello M, Griffin RJ, Joiner MC, Burmeister J. Three discipline collaborative radiation therapy (3DCRT) special debate: The United States needs at least one carbon ion facility. J Appl Clin Med Phys. 2019 Nov; 20(11):6-13.
    View in: PubMed
    Score: 0.007
  59. Paidi SK, Diaz PM, Dadgar S, Jenkins SV, Quick CM, Griffin RJ, Dings RPM, Rajaram N, Barman I. Label-Free Raman Spectroscopy Reveals Signatures of Radiation Resistance in the Tumor Microenvironment. Cancer Res. 2019 04 15; 79(8):2054-2064.
    View in: PubMed
    Score: 0.007
  60. Mohindra P, Sawant A, Griffin RJ, Lamichhane N, Vlashi E, Xu-Welliver M, Dominello M, Joiner MC, Burmeister J. Three discipline collaborative radiation therapy (3DCRT) special debate: I would treat all early-stage NSCLC patients with SBRT. J Appl Clin Med Phys. 2019 03; 20(3):7-13.
    View in: PubMed
    Score: 0.007
  61. Miousse IR, Tobacyk J, Quick CM, Jamshidi-Parsian A, Skinner CM, Kore R, Melnyk SB, Kutanzi KR, Xia F, Griffin RJ, Koturbash I. Modulation of dietary methionine intake elicits potent, yet distinct, anticancer effects on primary versus metastatic tumors. Carcinogenesis. 2018 09 21; 39(9):1117-1126.
    View in: PubMed
    Score: 0.006
  62. Jamshidi-Parsian A, Griffin RJ, Kore RA, Todorova VK, Makhoul I. Tumor-endothelial cell interaction in an experimental model of human hepatocellular carcinoma. Exp Cell Res. 2018 11 01; 372(1):16-24.
    View in: PubMed
    Score: 0.006
  63. Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, B?ck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesqui?re B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW. Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis. 2018 08; 21(3):425-532.
    View in: PubMed
    Score: 0.006
  64. Moore CL, Taylor EM, Ball KK, Bernock LJ, Griffin RJ, Jung S, Shoeib A, Borrelli MJ. Quantitative microinjection using fluorescence calibration of streaming microdroplets on a superhydrophobic surface. Exp Cell Res. 2018 09 15; 370(2):426-433.
    View in: PubMed
    Score: 0.006
  65. Lee DE, Alhallak K, Jenkins SV, Vargas I, Greene NP, Quinn KP, Griffin RJ, Dings RPM, Rajaram N. A Radiosensitizing Inhibitor of HIF-1 alters the Optical Redox State of Human Lung Cancer Cells In Vitro. Sci Rep. 2018 06 11; 8(1):8815.
    View in: PubMed
    Score: 0.006
  66. Kirsch DG, Diehn M, Kesarwala AH, Maity A, Morgan MA, Schwarz JK, Bristow R, Demaria S, Eke I, Griffin RJ, Haas-Kogan D, Higgins GS, Kimmelman AC, Kimple RJ, Lombaert IM, Ma L, Marples B, Pajonk F, Park CC, Schaue D, Tran PT, Bernhard EJ. The Future of Radiobiology. J Natl Cancer Inst. 2018 04 01; 110(4):329-340.
    View in: PubMed
    Score: 0.006
  67. Dings RPM, Miller MC, Griffin RJ, Mayo KH. Galectins as Molecular Targets for Therapeutic Intervention. Int J Mol Sci. 2018 Mar 19; 19(3).
    View in: PubMed
    Score: 0.006
  68. Hyer ML, Milhollen MA, Ciavarri J, Fleming P, Traore T, Sappal D, Huck J, Shi J, Gavin J, Brownell J, Yang Y, Stringer B, Griffin R, Bruzzese F, Soucy T, Duffy J, Rabino C, Riceberg J, Hoar K, Lublinsky A, Menon S, Sintchak M, Bump N, Pulukuri SM, Langston S, Tirrell S, Kuranda M, Veiby P, Newcomb J, Li P, Wu JT, Powe J, Dick LR, Greenspan P, Galvin K, Manfredi M, Claiborne C, Amidon BS, Bence NF. A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment. Nat Med. 2018 02; 24(2):186-193.
    View in: PubMed
    Score: 0.006
  69. Miousse IR, Ewing LE, Kutanzi KR, Griffin RJ, Koturbash I. DNA Methylation in Radiation-Induced Carcinogenesis: Experimental Evidence and Clinical Perspectives. Crit Rev Oncog. 2018; 23(1-2):1-11.
    View in: PubMed
    Score: 0.006
  70. Wyatt KH, Griffin R, Guerry AD, Ruckelshaus M, Fogarty M, Arkema KK. Habitat risk assessment for regional ocean planning in the U.S. Northeast and Mid-Atlantic. PLoS One. 2017; 12(12):e0188776.
    View in: PubMed
    Score: 0.006
  71. Koonce NA, Griffin RJ, Dings RPM. Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models. Int J Mol Sci. 2017 Dec 09; 18(12).
    View in: PubMed
    Score: 0.006
  72. Shi P, Liao M, Chuang BC, Griffin R, Shi J, Hyer M, Fallon JK, Smith PC, Li C, Xia CQ. Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and alters drug-drug interaction profiles. Xenobiotica. 2018 Nov; 48(11):1173-1183.
    View in: PubMed
    Score: 0.006
  73. Darrigues E, Dantuluri V, Nima ZA, Vang-Dings KB, Griffin RJ, Biris AR, Ghosh A, Biris AS. Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance. Part 2: Treatment. Drug Metab Rev. 2017 05; 49(2):253-283.
    View in: PubMed
    Score: 0.006
  74. Darrigues E, Nima ZA, Majeed W, Vang-Dings KB, Dantuluri V, Biris AR, Zharov VP, Griffin RJ, Biris AS. Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance.Part 1: Diagnosis. Drug Metab Rev. 2017 05; 49(2):212-252.
    View in: PubMed
    Score: 0.006
  75. Alhallak K, Jenkins SV, Lee DE, Greene NP, Quinn KP, Griffin RJ, Dings RPM, Rajaram N. Optical imaging of radiation-induced metabolic changes in radiation-sensitive and resistant cancer cells. J Biomed Opt. 2017 06 01; 22(6):60502.
    View in: PubMed
    Score: 0.006
  76. Adams R, Burnley RJ, Valenzano CR, Qureshi O, Doyle C, Lumb S, Del Carmen Lopez M, Griffin R, McMillan D, Taylor RD, Meier C, Mori P, Griffin LM, Wernery U, Kinne J, Rapecki S, Baker TS, Lawson AD, Wright M, Ettorre A. Discovery of a junctional epitope antibody that stabilizes IL-6 and gp80 protein:protein interaction and modulates its downstream signaling. Sci Rep. 2017 01 30; 7:37716.
    View in: PubMed
    Score: 0.006
  77. Makhoul I, Todorova VK, Siegel ER, Erickson SW, Dhakal I, Raj VR, Lee JY, Orloff MS, Griffin RJ, Henry-Tillman RS, Klimberg S, Hutchins LF, Kadlubar SA. Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients. PLoS One. 2017; 12(1):e0168550.
    View in: PubMed
    Score: 0.006
  78. Nolan J, Sarimollaoglu M, Nedosekin DA, Jamshidi-Parsian A, Galanzha EI, Kore RA, Griffin RJ, Zharov VP. In Vivo Flow Cytometry of Circulating Tumor-Associated Exosomes. Anal Cell Pathol (Amst). 2016; 2016:1628057.
    View in: PubMed
    Score: 0.006
  79. Makhoul I, Griffin RJ, Siegel E, Lee J, Dhakal I, Raj V, Jamshidi-Parsian A, Klimberg S, Hutchins LF, Kadlubar S. High-circulating Tie2 Is Associated With Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer. Am J Clin Oncol. 2016 06; 39(3):248-54.
    View in: PubMed
    Score: 0.006
  80. Sappington DR, Siegel ER, Hiatt G, Desai A, Penney RB, Jamshidi-Parsian A, Griffin RJ, Boysen G. Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A549 and H460 lung cancer cell lines. Biochim Biophys Acta. 2016 Apr; 1860(4):836-43.
    View in: PubMed
    Score: 0.005
  81. Zhang X, Penagaricano J, Yan Y, Liang X, Morrill S, Griffin RJ, Corry P, Ratanatharathorn V. Spatially fractionated radiotherapy (GRID) using helical tomotherapy. J Appl Clin Med Phys. 2016 01 08; 17(1):396-407.
    View in: PubMed
    Score: 0.005
  82. Guerry AD, Polasky S, Lubchenco J, Chaplin-Kramer R, Daily GC, Griffin R, Ruckelshaus M, Bateman IJ, Duraiappah A, Elmqvist T, Feldman MW, Folke C, Hoekstra J, Kareiva PM, Keeler BL, Li S, McKenzie E, Ouyang Z, Reyers B, Ricketts TH, Rockstr?m J, Tallis H, Vira B. Natural capital and ecosystem services informing decisions: From promise to practice. Proc Natl Acad Sci U S A. 2015 Jun 16; 112(24):7348-55.
    View in: PubMed
    Score: 0.005
  83. Song CW, Lee YJ, Griffin RJ, Park I, Koonce NA, Hui S, Kim MS, Dusenbery KE, Sperduto PW, Cho LC. Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):166-72.
    View in: PubMed
    Score: 0.005
  84. Song CW, Park I, Cho LC, Yuan J, Dusenbery KE, Griffin RJ, Levitt SH. Is indirect cell death involved in response of tumors to stereotactic radiosurgery and stereotactic body radiation therapy? Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):924-5.
    View in: PubMed
    Score: 0.005
  85. Song CW, Cho LC, Yuan J, Dusenbery KE, Griffin RJ, Levitt SH. Radiobiology of stereotactic body radiation therapy/stereotactic radiosurgery and the linear-quadratic model. Int J Radiat Oncol Biol Phys. 2013 Sep 01; 87(1):18-9.
    View in: PubMed
    Score: 0.004
  86. Shenoi MM, Iltis I, Choi J, Koonce NA, Metzger GJ, Griffin RJ, Bischof JC. Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy. Mol Pharm. 2013 May 06; 10(5):1683-94.
    View in: PubMed
    Score: 0.004
  87. Kim JW, Galanzha EI, Zaharoff DA, Griffin RJ, Zharov VP. Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo. Mol Pharm. 2013 Mar 04; 10(3):813-30.
    View in: PubMed
    Score: 0.004
  88. Park HJ, Griffin RJ, Hui S, Levitt SH, Song CW. Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res. 2012 Mar; 177(3):311-27.
    View in: PubMed
    Score: 0.004
  89. Chen D, Xia R, Chen X, Shafirstein G, Corry PM, Griffin RJ, Penagaricano JA, Tulunay-Ugur OE, Moros EG. SonoKnife: feasibility of a line-focused ultrasound device for thermal ablation therapy. Med Phys. 2011 Jul; 38(7):4372-85.
    View in: PubMed
    Score: 0.004
  90. Shenoi MM, Shah NB, Griffin RJ, Vercellotti GM, Bischof JC. Nanoparticle preconditioning for enhanced thermal therapies in cancer. Nanomedicine (Lond). 2011 Apr; 6(3):545-63.
    View in: PubMed
    Score: 0.004
  91. de Jong EP, Xie H, Onsongo G, Stone MD, Chen XB, Kooren JA, Refsland EW, Griffin RJ, Ondrey FG, Wu B, Le CT, Rhodus NL, Carlis JV, Griffin TJ. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PLoS One. 2010 Jun 17; 5(6):e11148.
    View in: PubMed
    Score: 0.004
  92. Evans KA, Budzik BW, Ross SA, Wisnoski DD, Jin J, Rivero RA, Vimal M, Szewczyk GR, Jayawickreme C, Moncol DL, Rimele TJ, Armour SL, Weaver SP, Griffin RJ, Tadepalli SM, Jeune MR, Shearer TW, Chen ZB, Chen L, Anderson DL, Becherer JD, De Los Frailes M, Colilla FJ. Discovery of 3-aryl-4-isoxazolecarboxamides as TGR5 receptor agonists. J Med Chem. 2009 Dec 24; 52(24):7962-5.
    View in: PubMed
    Score: 0.004
  93. Suva LJ, Griffin RJ, Makhoul I. Mechanisms of bone metastases of breast cancer. Endocr Relat Cancer. 2009 Sep; 16(3):703-13.
    View in: PubMed
    Score: 0.003
  94. Pe?agar?cano JA, Griffin R, Corry P, Moros E, Yan Y, Ratanatharathorn V. Spatially fractionated (GRID) therapy for large and bulky tumors. J Ark Med Soc. 2009 May; 105(11):263-5.
    View in: PubMed
    Score: 0.003
  95. McTavish H, Griffin RJ, Terai K, Dudek AZ. Novel insulin-like growth factor-methotrexate covalent conjugate inhibits tumor growth in vivo at lower dosage than methotrexate alone. Transl Res. 2009 Jun; 153(6):275-82.
    View in: PubMed
    Score: 0.003
  96. Waterson AG, Petrov KG, Hornberger KR, Hubbard RD, Sammond DM, Smith SC, Dickson HD, Caferro TR, Hinkle KW, Stevens KL, Dickerson SH, Rusnak DW, Spehar GM, Wood ER, Griffin RJ, Uehling DE. Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors. Bioorg Med Chem Lett. 2009 Mar 01; 19(5):1332-6.
    View in: PubMed
    Score: 0.003
  97. Dings RP, Van Laar ES, Webber J, Zhang Y, Griffin RJ, Waters SJ, MacDonald JR, Mayo KH. Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven. Cancer Lett. 2008 Jul 08; 265(2):270-80.
    View in: PubMed
    Score: 0.003
  98. Xie H, Onsongo G, Popko J, de Jong EP, Cao J, Carlis JV, Griffin RJ, Rhodus NL, Griffin TJ. Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol Cell Proteomics. 2008 Mar; 7(3):486-98.
    View in: PubMed
    Score: 0.003
  99. Choi EK, Terai K, Ji IM, Kook YH, Park KH, Oh ET, Griffin RJ, Lim BU, Kim JS, Lee DS, Boothman DA, Loren M, Song CW, Park HJ. Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells. Neoplasia. 2007 Aug; 9(8):634-42.
    View in: PubMed
    Score: 0.003
  100. Choi EK, Ji IM, Lee SR, Kook YH, Griffin RJ, Lim BU, Kim JS, Lee DS, Song CW, Park HJ. Radiosensitization of tumor cells by modulation of ATM kinase. Int J Radiat Biol. 2006 Apr; 82(4):277-83.
    View in: PubMed
    Score: 0.003
  101. Park HJ, Choi EK, Choi J, Ahn KJ, Kim EJ, Ji IM, Kook YH, Ahn SD, Williams B, Griffin R, Boothman DA, Lee CK, Song CW. Heat-induced up-regulation of NAD(P)H:quinone oxidoreductase potentiates anticancer effects of beta-lapachone. Clin Cancer Res. 2005 Dec 15; 11(24 Pt 1):8866-71.
    View in: PubMed
    Score: 0.003
  102. Xie H, Rhodus NL, Griffin RJ, Carlis JV, Griffin TJ. A catalogue of human saliva proteins identified by free flow electrophoresis-based peptide separation and tandem mass spectrometry. Mol Cell Proteomics. 2005 Nov; 4(11):1826-30.
    View in: PubMed
    Score: 0.003
  103. Choi EK, Roberts KP, Griffin RJ, Han T, Park HJ, Song CW, Park HJ. Effect of pH on radiation-induced p53 expression. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1264-71.
    View in: PubMed
    Score: 0.002
  104. Tavares FX, Boucheron JA, Dickerson SH, Griffin RJ, Preugschat F, Thomson SA, Wang TY, Zhou HQ. N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy. J Med Chem. 2004 Sep 09; 47(19):4716-30.
    View in: PubMed
    Score: 0.002
  105. Chung HS, Park SR, Choi EK, Park HJ, Griffin RJ, Song CW, Park H. Role of sphingomyelin-MAPKs pathway in heat-induced apoptosis. Exp Mol Med. 2003 Jun 30; 35(3):181-8.
    View in: PubMed
    Score: 0.002
  106. Gaul MD, Guo Y, Affleck K, Cockerill GS, Gilmer TM, Griffin RJ, Guntrip S, Keith BR, Knight WB, Mullin RJ, Murray DM, Rusnak DW, Smith K, Tadepalli S, Wood ER, Lackey K. Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines. Bioorg Med Chem Lett. 2003 Feb 24; 13(4):637-40.
    View in: PubMed
    Score: 0.002
  107. Park HJ, Lee SH, Chung H, Rhee YH, Lim BU, Ha SW, Griffin RJ, Lee HS, Song CW, Choi EK. Influence of environmental pH on G2-phase arrest caused by ionizing radiation. Radiat Res. 2003 Jan; 159(1):86-93.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.